These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24944605)

  • 21. Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.
    Kodaira K; Kikuchi E; Kosugi M; Horiguchi Y; Matsumoto K; Kanai K; Suzuki E; Miyajima A; Nakagawa K; Tachibana M; Umezawa K; Oya M
    Urology; 2010 Apr; 75(4):805-12. PubMed ID: 20156648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.
    Zhou LL; Wei W; Si JF; Yuan DP
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20706659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
    Shimo T; Adachi Y; Yamanouchi S; Tsuji S; Kimata T; Umezawa K; Okigaki M; Takaya J; Ikehara S; Kaneko K
    Am J Nephrol; 2013; 37(4):302-9. PubMed ID: 23548793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner.
    Tatetsu H; Okuno Y; Nakamura M; Matsuno F; Sonoki T; Taniguchi I; Uneda S; Umezawa K; Mitsuya H; Hata H
    Mol Cancer Ther; 2005 Jul; 4(7):1114-20. PubMed ID: 16020669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
    Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
    Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin.
    Ariga A; Namekawa J; Matsumoto N; Inoue J; Umezawa K
    J Biol Chem; 2002 Jul; 277(27):24625-30. PubMed ID: 11983688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (E)-3-(3,4-Dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one ameliorates the collagen-arthritis via blocking ERK/JNK and NF-κB signaling pathway.
    Li X; Peng F; Xie C; Wu W; Han X; Chen L
    Int Immunopharmacol; 2013 Dec; 17(4):1125-33. PubMed ID: 24135236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance.
    Watanabe M; Yamashita K; Kamachi H; Kuraya D; Koshizuka Y; Shibasaki S; Asahi Y; Ono H; Emoto S; Ogura M; Yoshida T; Ozaki M; Umezawa K; Matsushita M; Todo S
    Transplantation; 2013 Sep; 96(5):454-62. PubMed ID: 23860082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Inflammatory Effect of Dehydroxymethylepoxyquinomicin, a Nuclear factor-κB Inhibitor, on Endotoxin-Induced Uveitis in Rats In vivo and In vitro.
    Ando Y; Keino H; Kudo A; Hirakata A; Okada AA; Umezawa K
    Ocul Immunol Inflamm; 2020; 28(2):240-248. PubMed ID: 30950670
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
    Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
    Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
    Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: I. HMGB1 suppression by DHMEQ prevents early islet graft damage.
    Kuraya D; Watanabe M; Koshizuka Y; Ogura M; Yoshida T; Asahi Y; Kamachi H; Nakamura T; Harashima H; Ozaki M; Umezawa K; Matsushita M; Yamashita K; Todo S
    Transplantation; 2013 Sep; 96(5):445-53. PubMed ID: 23900151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus.
    Pannu N; Bhatnagar A
    Immunobiology; 2020 Jan; 225(1):151871. PubMed ID: 31780314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
    Satoh M; Kumar A; Kanwar YS; Reeves WH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10934-8. PubMed ID: 7479913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.
    Satoh M; Reeves WH
    J Exp Med; 1994 Dec; 180(6):2341-6. PubMed ID: 7964507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice.
    Lin Y; Yan Y; Zhang H; Chen Y; He Y; Wang S; Fang L; Lv Y; Du G
    Acta Pharm Sin B; 2017 Mar; 7(2):159-166. PubMed ID: 28303221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chebulanin exerts its anti-inflammatory and anti-arthritic effects via inhibiting NF-κB and MAPK activation in collagen-induced arthritis mice.
    Liu F; Liu Y; Zhan S; Lv J; Sun F; Weng B; Liu S; Xia P
    Int Immunopharmacol; 2020 Nov; 88():106823. PubMed ID: 32795901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.